Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2402 USD | +1.35% | -11.37% | -86.80% |
04-15 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
04-12 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.75M 380M |
---|---|---|---|---|---|
Net income 2024 * | -51M -4.08B | Net income 2025 * | -16M -1.28B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.09
x | P/E ratio 2025 * |
-0.37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.18% |
1 day | +1.35% | ||
1 week | -11.37% | ||
Current month | -57.36% | ||
1 month | -57.36% | ||
3 months | -71.37% | ||
6 months | -88.05% | ||
Current year | -86.80% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Walters
CEO | Chief Executive Officer | 57 | 31/07/16 |
Allan Shaw
DFI | Director of Finance/CFO | 59 | 11/05/20 |
Steve Innaimo
COO | Chief Operating Officer | - | 07/01/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Bailey
FOU | Founder | 68 | 31/12/72 |
Steven Mintz
BRD | Director/Board Member | 57 | 05/04/16 |
Robert Glassman
BRD | Director/Board Member | 62 | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.2402 | +1.35% | 63,299 |
25/04/24 | 0.237 | -5.28% | 41,418 |
24/04/24 | 0.2502 | +3.13% | 187,060 |
23/04/24 | 0.2426 | -18.37% | 169,111 |
22/04/24 | 0.2972 | +9.67% | 430,127 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.80% | 4.75M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PRTG Stock